Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Radioactive Stents Market by Product (Retrograde Stents, Antegrade Stents, Internal (Double-J) Stents, Iodine-125 Radioactive Stents, Others) and by Application (Lithotripsy, Ureteroscopy, Ureteroenoscopy, Percutaneous Nephrolithotomy, Angiography, Neointimal Hyperplasia, Esophageal Cancer, Biliary Cancer, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

A03416

Pages: NA

Charts: NA

Tables: NA

Radioactive stents are small expandable tubes that are used in prevention of restenosis and coronary artery lesions, and in improving catheter-based revascularization. These stents are widely utilized in cancer treatment as they utilize high-energy gamma rays that destroy the cancer cells and prevent their proliferation.

Increase in incidence of coronary artery disease, emergence of innovative radioactive stents, and improved clinical outcomes due to stenting drive the market growth. In addition, rise in incidence of chronic & lifestyle diseases, especially diabetes and obesity, and improved insurance & reimbursement towards radioactive stents supplement the market growth. However, availability of alternative methods for coronary heart disease treatment and high cost of treatment-associated radioactive stents impede the market growth. Furthermore, the untapped emerging countries present lucrative opportunities for market expansion.

The global radioactive stents market is segmented based on product, application, stent size, and geography. Based on product, it is categorized into retrograde stents, antegrade stents, internal (double-j) stents, iodine-125 radioactive stent, and others. In terms of application, it is divided into lithotripsy, ureteroscopy, ureteroenoscopy, percutaneous nephrolithotomy, angiography, neointimal hyperplasia, esophageal cancer, biliary cancer, and others. Based on stent size, it is classified into 18 mm, 20 mm, 14 mm, and other stents. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Product development is the key strategy adopted by major players in the radioactive stents market players. The report provides a comprehensive analysis of the key players that operate in the global radioactive stents market. The key player of the market includes C.R. Bard, Inc., Cook Medical Inc., Medline Industries Ltd, Pnn Medical A/S, Allium Medical Solutions Ltd., APC Cardiovascular Ltd., Micro-Tech Pvt. Ltd., Changzhou Zhiye Co Ltd., Aetna Inc., and Abbott Laboratories.

Key Benefits

  • The study provides an in-depth analysis of the global radioactive stents market, and the current trends and future estimations to elucidate the imminent investment pockets .
  • It presents quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the market based on product type assists in understanding the trends in the industry.
  • Key market players and their strategies are thoroughly analyzed to understand the competitive outlook of the industry.

 Key Market Segments

  • By Product
    • Retrograde Stents
    • Antegrade Stents
    • Internal (Double-J) Stents
    • Iodine-125 Radioactive Stents
    • Others
  • By Application
    • Lithotripsy
    • Ureteroscopy
    • Ureteroenoscopy
    • Percutaneous Nephrolithotomy
    • Angiography
    • Neointimal Hyperplasia
    • Esophageal Cancer
    • Biliary Cancer
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • C.R. Bard, Inc.
  • Aetna Inc.
  • APC Cardiovascular Ltd.
  • Allium Medical Solutions Ltd.
  • Medline Industries Ltd
  • Changzhou Zhiye Co Ltd.
  • Pnn Medical A/S
  • Micro-Tech Pvt. Ltd
  • Cook Medical Inc.
  • Abbott Laboratories.

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: RADIOACTIVE STENTS MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Retrograde Stents

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Antegrade Stents

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Internal (Double-J) Stents

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Iodine-125 Radioactive Stents

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Others

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

  • CHAPTER 5: RADIOACTIVE STENTS MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Lithotripsy

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Ureteroscopy

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Ureteroenoscopy

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Percutaneous Nephrolithotomy

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Angiography

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

    • 5.7. Neointimal Hyperplasia

      • 5.7.1. Key Market Trends, Growth Factors and Opportunities

      • 5.7.2. Market Size and Forecast, By Region

      • 5.7.3. Market Share Analysis, By Country

    • 5.8. Esophageal Cancer

      • 5.8.1. Key Market Trends, Growth Factors and Opportunities

      • 5.8.2. Market Size and Forecast, By Region

      • 5.8.3. Market Share Analysis, By Country

    • 5.9. Biliary Cancer

      • 5.9.1. Key Market Trends, Growth Factors and Opportunities

      • 5.9.2. Market Size and Forecast, By Region

      • 5.9.3. Market Share Analysis, By Country

    • 5.10. Others

      • 5.10.1. Key Market Trends, Growth Factors and Opportunities

      • 5.10.2. Market Size and Forecast, By Region

      • 5.10.3. Market Share Analysis, By Country

  • CHAPTER 6: RADIOACTIVE STENTS MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Product

      • 6.2.3. Market Size and Forecast, By Application

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Radioactive Stents Market

        • 6.2.5.1. Market Size and Forecast, By Product
        • 6.2.5.2. Market Size and Forecast, By Application

      • 6.2.6. Canada Radioactive Stents Market

        • 6.2.6.1. Market Size and Forecast, By Product
        • 6.2.6.2. Market Size and Forecast, By Application

      • 6.2.7. Mexico Radioactive Stents Market

        • 6.2.7.1. Market Size and Forecast, By Product
        • 6.2.7.2. Market Size and Forecast, By Application

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Product

      • 6.3.3. Market Size and Forecast, By Application

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Radioactive Stents Market

        • 6.3.5.1. Market Size and Forecast, By Product
        • 6.3.5.2. Market Size and Forecast, By Application

      • 6.3.6. Germany Radioactive Stents Market

        • 6.3.6.1. Market Size and Forecast, By Product
        • 6.3.6.2. Market Size and Forecast, By Application

      • 6.3.7. Italy Radioactive Stents Market

        • 6.3.7.1. Market Size and Forecast, By Product
        • 6.3.7.2. Market Size and Forecast, By Application

      • 6.3.8. Spain Radioactive Stents Market

        • 6.3.8.1. Market Size and Forecast, By Product
        • 6.3.8.2. Market Size and Forecast, By Application

      • 6.3.9. UK Radioactive Stents Market

        • 6.3.9.1. Market Size and Forecast, By Product
        • 6.3.9.2. Market Size and Forecast, By Application

      • 6.3.10. Russia Radioactive Stents Market

        • 6.3.10.1. Market Size and Forecast, By Product
        • 6.3.10.2. Market Size and Forecast, By Application

      • 6.3.11. Rest Of Europe Radioactive Stents Market

        • 6.3.11.1. Market Size and Forecast, By Product
        • 6.3.11.2. Market Size and Forecast, By Application

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Product

      • 6.4.3. Market Size and Forecast, By Application

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Radioactive Stents Market

        • 6.4.5.1. Market Size and Forecast, By Product
        • 6.4.5.2. Market Size and Forecast, By Application

      • 6.4.6. Japan Radioactive Stents Market

        • 6.4.6.1. Market Size and Forecast, By Product
        • 6.4.6.2. Market Size and Forecast, By Application

      • 6.4.7. India Radioactive Stents Market

        • 6.4.7.1. Market Size and Forecast, By Product
        • 6.4.7.2. Market Size and Forecast, By Application

      • 6.4.8. South Korea Radioactive Stents Market

        • 6.4.8.1. Market Size and Forecast, By Product
        • 6.4.8.2. Market Size and Forecast, By Application

      • 6.4.9. Australia Radioactive Stents Market

        • 6.4.9.1. Market Size and Forecast, By Product
        • 6.4.9.2. Market Size and Forecast, By Application

      • 6.4.10. Thailand Radioactive Stents Market

        • 6.4.10.1. Market Size and Forecast, By Product
        • 6.4.10.2. Market Size and Forecast, By Application

      • 6.4.11. Malaysia Radioactive Stents Market

        • 6.4.11.1. Market Size and Forecast, By Product
        • 6.4.11.2. Market Size and Forecast, By Application

      • 6.4.12. Indonesia Radioactive Stents Market

        • 6.4.12.1. Market Size and Forecast, By Product
        • 6.4.12.2. Market Size and Forecast, By Application

      • 6.4.13. Rest of Asia Pacific Radioactive Stents Market

        • 6.4.13.1. Market Size and Forecast, By Product
        • 6.4.13.2. Market Size and Forecast, By Application

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Product

      • 6.5.3. Market Size and Forecast, By Application

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Radioactive Stents Market

        • 6.5.5.1. Market Size and Forecast, By Product
        • 6.5.5.2. Market Size and Forecast, By Application

      • 6.5.6. South Africa Radioactive Stents Market

        • 6.5.6.1. Market Size and Forecast, By Product
        • 6.5.6.2. Market Size and Forecast, By Application

      • 6.5.7. Saudi Arabia Radioactive Stents Market

        • 6.5.7.1. Market Size and Forecast, By Product
        • 6.5.7.2. Market Size and Forecast, By Application

      • 6.5.8. UAE Radioactive Stents Market

        • 6.5.8.1. Market Size and Forecast, By Product
        • 6.5.8.2. Market Size and Forecast, By Application

      • 6.5.9. Argentina Radioactive Stents Market

        • 6.5.9.1. Market Size and Forecast, By Product
        • 6.5.9.2. Market Size and Forecast, By Application

      • 6.5.10. Rest of LAMEA Radioactive Stents Market

        • 6.5.10.1. Market Size and Forecast, By Product
        • 6.5.10.2. Market Size and Forecast, By Application

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. C.R. Bard, Inc.

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Cook Medical Inc.

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Medline Industries Ltd

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Pnn Medical A/S

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Allium Medical Solutions Ltd.

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. APC Cardiovascular Ltd.

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Micro-Tech Pvt. Ltd

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Changzhou Zhiye Co Ltd.

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Aetna Inc.

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Abbott Laboratories.

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL RADIOACTIVE STENTS MARKET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL RADIOACTIVE STENTS MARKET FOR RETROGRADE STENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL RADIOACTIVE STENTS MARKET FOR ANTEGRADE STENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL RADIOACTIVE STENTS MARKET FOR INTERNAL (DOUBLE-J) STENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL RADIOACTIVE STENTS MARKET FOR IODINE-125 RADIOACTIVE STENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL RADIOACTIVE STENTS MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL RADIOACTIVE STENTS MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL RADIOACTIVE STENTS MARKET FOR LITHOTRIPSY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL RADIOACTIVE STENTS MARKET FOR URETEROSCOPY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL RADIOACTIVE STENTS MARKET FOR URETEROENOSCOPY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL RADIOACTIVE STENTS MARKET FOR PERCUTANEOUS NEPHROLITHOTOMY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL RADIOACTIVE STENTS MARKET FOR ANGIOGRAPHY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL RADIOACTIVE STENTS MARKET FOR NEOINTIMAL HYPERPLASIA, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL RADIOACTIVE STENTS MARKET FOR ESOPHAGEAL CANCER, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL RADIOACTIVE STENTS MARKET FOR BILIARY CANCER, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. GLOBAL RADIOACTIVE STENTS MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 17. GLOBAL RADIOACTIVE STENTS MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 18. NORTH AMERICA RADIOACTIVE STENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 19. NORTH AMERICA RADIOACTIVE STENTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 20. NORTH AMERICA RADIOACTIVE STENTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 21. U.S. RADIOACTIVE STENTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 22. U.S. RADIOACTIVE STENTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 23. CANADA RADIOACTIVE STENTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 24. CANADA RADIOACTIVE STENTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 25. MEXICO RADIOACTIVE STENTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 26. MEXICO RADIOACTIVE STENTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 27. EUROPE RADIOACTIVE STENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 28. EUROPE RADIOACTIVE STENTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 29. EUROPE RADIOACTIVE STENTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 30. FRANCE RADIOACTIVE STENTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 31. FRANCE RADIOACTIVE STENTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 32. GERMANY RADIOACTIVE STENTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 33. GERMANY RADIOACTIVE STENTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 34. ITALY RADIOACTIVE STENTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 35. ITALY RADIOACTIVE STENTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 36. SPAIN RADIOACTIVE STENTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 37. SPAIN RADIOACTIVE STENTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 38. UK RADIOACTIVE STENTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 39. UK RADIOACTIVE STENTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 40. RUSSIA RADIOACTIVE STENTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 41. RUSSIA RADIOACTIVE STENTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 42. REST OF EUROPE RADIOACTIVE STENTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 43. REST OF EUROPE RADIOACTIVE STENTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 44. ASIA-PACIFIC RADIOACTIVE STENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 45. ASIA-PACIFIC RADIOACTIVE STENTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 46. ASIA-PACIFIC RADIOACTIVE STENTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 47. CHINA RADIOACTIVE STENTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 48. CHINA RADIOACTIVE STENTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 49. JAPAN RADIOACTIVE STENTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 50. JAPAN RADIOACTIVE STENTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 51. INDIA RADIOACTIVE STENTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 52. INDIA RADIOACTIVE STENTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 53. SOUTH KOREA RADIOACTIVE STENTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 54. SOUTH KOREA RADIOACTIVE STENTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 55. AUSTRALIA RADIOACTIVE STENTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 56. AUSTRALIA RADIOACTIVE STENTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 57. THAILAND RADIOACTIVE STENTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 58. THAILAND RADIOACTIVE STENTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 59. MALAYSIA RADIOACTIVE STENTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 60. MALAYSIA RADIOACTIVE STENTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 61. INDONESIA RADIOACTIVE STENTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 62. INDONESIA RADIOACTIVE STENTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 63. REST OF ASIA PACIFIC RADIOACTIVE STENTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 64. REST OF ASIA PACIFIC RADIOACTIVE STENTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 65. LAMEA RADIOACTIVE STENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 66. LAMEA RADIOACTIVE STENTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 67. LAMEA RADIOACTIVE STENTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 68. BRAZIL RADIOACTIVE STENTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 69. BRAZIL RADIOACTIVE STENTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 70. SOUTH AFRICA RADIOACTIVE STENTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 71. SOUTH AFRICA RADIOACTIVE STENTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 72. SAUDI ARABIA RADIOACTIVE STENTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 73. SAUDI ARABIA RADIOACTIVE STENTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 74. UAE RADIOACTIVE STENTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 75. UAE RADIOACTIVE STENTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 76. ARGENTINA RADIOACTIVE STENTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 77. ARGENTINA RADIOACTIVE STENTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 78. REST OF LAMEA RADIOACTIVE STENTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 79. REST OF LAMEA RADIOACTIVE STENTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 80. C.R. BARD, INC.: KEY EXECUTIVES
  • TABLE 81. C.R. BARD, INC.: COMPANY SNAPSHOT
  • TABLE 82. C.R. BARD, INC.: OPERATING SEGMENTS
  • TABLE 83. C.R. BARD, INC.: PRODUCT PORTFOLIO
  • TABLE 84. C.R. BARD, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 85. COOK MEDICAL INC.: KEY EXECUTIVES
  • TABLE 86. COOK MEDICAL INC.: COMPANY SNAPSHOT
  • TABLE 87. COOK MEDICAL INC.: OPERATING SEGMENTS
  • TABLE 88. COOK MEDICAL INC.: PRODUCT PORTFOLIO
  • TABLE 89. COOK MEDICAL INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 90. MEDLINE INDUSTRIES LTD: KEY EXECUTIVES
  • TABLE 91. MEDLINE INDUSTRIES LTD: COMPANY SNAPSHOT
  • TABLE 92. MEDLINE INDUSTRIES LTD: OPERATING SEGMENTS
  • TABLE 93. MEDLINE INDUSTRIES LTD: PRODUCT PORTFOLIO
  • TABLE 94. MEDLINE INDUSTRIES LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 95. PNN MEDICAL A/S: KEY EXECUTIVES
  • TABLE 96. PNN MEDICAL A/S: COMPANY SNAPSHOT
  • TABLE 97. PNN MEDICAL A/S: OPERATING SEGMENTS
  • TABLE 98. PNN MEDICAL A/S: PRODUCT PORTFOLIO
  • TABLE 99. PNN MEDICAL A/S: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 100. ALLIUM MEDICAL SOLUTIONS LTD.: KEY EXECUTIVES
  • TABLE 101. ALLIUM MEDICAL SOLUTIONS LTD.: COMPANY SNAPSHOT
  • TABLE 102. ALLIUM MEDICAL SOLUTIONS LTD.: OPERATING SEGMENTS
  • TABLE 103. ALLIUM MEDICAL SOLUTIONS LTD.: PRODUCT PORTFOLIO
  • TABLE 104. ALLIUM MEDICAL SOLUTIONS LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 105. APC CARDIOVASCULAR LTD.: KEY EXECUTIVES
  • TABLE 106. APC CARDIOVASCULAR LTD.: COMPANY SNAPSHOT
  • TABLE 107. APC CARDIOVASCULAR LTD.: OPERATING SEGMENTS
  • TABLE 108. APC CARDIOVASCULAR LTD.: PRODUCT PORTFOLIO
  • TABLE 109. APC CARDIOVASCULAR LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 110. MICRO-TECH PVT. LTD: KEY EXECUTIVES
  • TABLE 111. MICRO-TECH PVT. LTD: COMPANY SNAPSHOT
  • TABLE 112. MICRO-TECH PVT. LTD: OPERATING SEGMENTS
  • TABLE 113. MICRO-TECH PVT. LTD: PRODUCT PORTFOLIO
  • TABLE 114. MICRO-TECH PVT. LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 115. CHANGZHOU ZHIYE CO LTD.: KEY EXECUTIVES
  • TABLE 116. CHANGZHOU ZHIYE CO LTD.: COMPANY SNAPSHOT
  • TABLE 117. CHANGZHOU ZHIYE CO LTD.: OPERATING SEGMENTS
  • TABLE 118. CHANGZHOU ZHIYE CO LTD.: PRODUCT PORTFOLIO
  • TABLE 119. CHANGZHOU ZHIYE CO LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 120. AETNA INC.: KEY EXECUTIVES
  • TABLE 121. AETNA INC.: COMPANY SNAPSHOT
  • TABLE 122. AETNA INC.: OPERATING SEGMENTS
  • TABLE 123. AETNA INC.: PRODUCT PORTFOLIO
  • TABLE 124. AETNA INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 125. ABBOTT LABORATORIES.: KEY EXECUTIVES
  • TABLE 126. ABBOTT LABORATORIES.: COMPANY SNAPSHOT
  • TABLE 127. ABBOTT LABORATORIES.: OPERATING SEGMENTS
  • TABLE 128. ABBOTT LABORATORIES.: PRODUCT PORTFOLIO
  • TABLE 129. ABBOTT LABORATORIES.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL RADIOACTIVE STENTS MARKET SEGMENTATION
  • FIGURE 2. GLOBAL RADIOACTIVE STENTS MARKET
  • FIGURE 3. SEGMENTATION RADIOACTIVE STENTS MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN RADIOACTIVE STENTS MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALRADIOACTIVE STENTS MARKET
  • FIGURE 11. RADIOACTIVE STENTS MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. RADIOACTIVE STENTS MARKET FOR RETROGRADE STENTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. RADIOACTIVE STENTS MARKET FOR ANTEGRADE STENTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. RADIOACTIVE STENTS MARKET FOR INTERNAL (DOUBLE-J) STENTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. RADIOACTIVE STENTS MARKET FOR IODINE-125 RADIOACTIVE STENTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. RADIOACTIVE STENTS MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. RADIOACTIVE STENTS MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 18. RADIOACTIVE STENTS MARKET FOR LITHOTRIPSY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. RADIOACTIVE STENTS MARKET FOR URETEROSCOPY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. RADIOACTIVE STENTS MARKET FOR URETEROENOSCOPY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. RADIOACTIVE STENTS MARKET FOR PERCUTANEOUS NEPHROLITHOTOMY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. RADIOACTIVE STENTS MARKET FOR ANGIOGRAPHY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. RADIOACTIVE STENTS MARKET FOR NEOINTIMAL HYPERPLASIA, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. RADIOACTIVE STENTS MARKET FOR ESOPHAGEAL CANCER, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 25. RADIOACTIVE STENTS MARKET FOR BILIARY CANCER, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 26. RADIOACTIVE STENTS MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 27. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 28. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 29. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 30. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 31. COMPETITIVE DASHBOARD
  • FIGURE 32. COMPETITIVE HEATMAP: RADIOACTIVE STENTS MARKET
  • FIGURE 33. TOP PLAYER POSITIONING, 2024
  • FIGURE 34. C.R. BARD, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 35. C.R. BARD, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 36. C.R. BARD, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 37. COOK MEDICAL INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 38. COOK MEDICAL INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 39. COOK MEDICAL INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 40. MEDLINE INDUSTRIES LTD: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 41. MEDLINE INDUSTRIES LTD: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 42. MEDLINE INDUSTRIES LTD: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 43. PNN MEDICAL A/S: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 44. PNN MEDICAL A/S: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 45. PNN MEDICAL A/S: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 46. ALLIUM MEDICAL SOLUTIONS LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 47. ALLIUM MEDICAL SOLUTIONS LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 48. ALLIUM MEDICAL SOLUTIONS LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 49. APC CARDIOVASCULAR LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 50. APC CARDIOVASCULAR LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 51. APC CARDIOVASCULAR LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 52. MICRO-TECH PVT. LTD: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 53. MICRO-TECH PVT. LTD: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 54. MICRO-TECH PVT. LTD: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 55. CHANGZHOU ZHIYE CO LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 56. CHANGZHOU ZHIYE CO LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 57. CHANGZHOU ZHIYE CO LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 58. AETNA INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 59. AETNA INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 60. AETNA INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 61. ABBOTT LABORATORIES.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 62. ABBOTT LABORATORIES.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 63. ABBOTT LABORATORIES.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Radioactive Stents Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved